Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_assertion type Assertion NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_head.
- NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_assertion description "[To further improve antigenicity, HER-2/neu was added to this panel as a marker antigen known to elicit HLA-A*02-restricted CTLs in patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_provenance.
- NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_assertion evidence source_evidence_literature NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_provenance.
- NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_assertion SIO_000772 15365776 NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_provenance.
- NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_assertion wasDerivedFrom befree-20140225 NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_provenance.
- NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_assertion wasGeneratedBy ECO_0000203 NP799718.RAvzMJCZ-9an0t1MDEiap2ogsxK5YPjL-FSgx10_fKIrM130_provenance.